niktimvo - axatilimab - csfr injection
(Axatilimab-Csfr)Incyte Corporation
Usage: Niktimvo treats chronic graft-versus-host disease (cGVHD) in adults and pediatric patients weighing at least 40 kg, after at least two prior systemic therapies have failed.